Press Release – New York, NY – August 6, 2020 – Sichenzia Ross Ference LLP today announced that it represented Aegis Capital Corp. as sole bookrunner in an underwritten public offering of 15,789,474 shares of the common stock of Avinger Inc. (NASDAQ: AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for diagnosis and treatment of patients with Peripheral Artery Disease (PAD), at a price of $0.38 per share. The offering was made pursuant to a registration statement on Form S-3 (No. 333-230124) which was previously filed with the Securities and Exchange Commission and declared effective on March 29, 2019.
The Sichenzia Ross Ference LLP team was led by partners Gregory Sichenzia, Darrin Ocasio, and Avital Perlman and associate Jacob Tabman.
- Sichenzia Ross Ference Carmel LLP Successfully Represents Defendants in Novel Southern District of New York Cryptocurrency Partnership Lawsuit - September 8, 2025
- Accounts Receivable / Accounts Payable Specialist - September 8, 2025
- Sichenzia Ross Ference Carmel LLP Represents Pineapple Financial in $100 Million Private Placement to Initiate Injective Digital Asset Treasury Strategy - September 8, 2025